Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases

References

• Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32
   PubMed Web of Science ®Google Scholar
• Shipton E. Post-surgical neuropathic pain. ANZ J Surg 2008;78:548-55
   PubMed Web of Science ®Google Scholar
• Reuben SS. Chronic pain after surgery: what can we do to prevent it. Curr Pain Headache Rep 2007;11:5-13
   PubMedGoogle Scholar
• Vadivelu N, Schreck M, Lopez J, et al. Pain after mastectomy and breast reconstruction. Am Surg 2008;74:285-96
   PubMed Web of Science ®Google Scholar
• Massaron S, Bona S, Fumagalli U, et al. Long-term sequelae after 1,311 primary inguinal hernia repairs. Hernia 2008;12:57-63
   PubMed Web of Science ®Google Scholar
• Wildgaard K, Ravn J, Kehlet H. Chronic post-thoracotomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiothorac Surg 2009;36:170-80
   PubMed Web of Science ®Google Scholar
• Vissers KC. The clinical challenge of chronic neuropathic pain. Disabil Rehabil 2006;28:343-9
   PubMed Web of Science ®Google Scholar
• Wallace MS, Wallace AM, Lee J, et al. Pain after breast surgery: a survey of 282 women. Pain 1996;66:195-205
   PubMed Web of Science ®Google Scholar
• Perttunen K, Tasmuth T, Kalso E. Chronic pain after thoracic surgery: a follow-up study. Acta Anaesthesiol Scand 1999;43:563-7
   PubMed Web of Science ®Google Scholar
• Gjeilo KH, Klepstad P, Wahba A, et al. Chronic pain after cardiac surgery: a prospective study. Acta Anaesthesiol Scand 2009 Aug 13 [Epub ahead of print]
   Google Scholar
• Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000;93:1123-33
   PubMed Web of Science ®Google Scholar
• van Hanswijck de Jonge P, Lloyd A, Horsfall L, et al. The measurement of chronic pain and health-related quality of life following inguinal hernia repair: a review of the literature. Hernia 2008;12:561-9
   PubMed Web of Science ®Google Scholar
• Vadalouca A, Siafaka I, Argyra E, et al. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment. Ann N Y Acad Sci 2006;1088:164-86
   PubMed Web of Science ®Google Scholar
• Katz NP, Gammaitoni AR, Davis MW, et al. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med 2002;3:324-32
   PubMed Web of Science ®Google Scholar
• Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Invest 2009;29:393-408
   PubMed Web of Science ®Google Scholar
• Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-305
   PubMed Web of Science ®Google Scholar
• Nayak S, Cunliffe M. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases. Paediatr Anaesth 2008;18:554-8
   PubMed Web of Science ®Google Scholar
• Hans GH, Robert DN, Van Maldeghem KN. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report. Spinal Cord 2008;46:311-13
   PubMed Web of Science ®Google Scholar
• Nalamachu S, Crockett RS, Gammaitoni AR, et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. MedGenMed 2006;8:33
   PubMedGoogle Scholar
• Herrmann DN, Barbano RL, Hart-Gouleau S, et al. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 2005;6:379-84
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009;25:1677-87
   PubMed Web of Science ®Google Scholar
• Kivitz A, Fairfax M, Sheldon EA, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 wekk, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther 2008;30:2366-77
   PubMed Web of Science ®Google Scholar
• Baliki MN, Geha PY, Jabakhanji R, et al. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 2008;4:47
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Galer BS, Onawola R, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 2004;20(Suppl 2):S13-19
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Lewis JE, Cole B, et al. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response. Pain Med 2006;7:135-42
   PubMed Web of Science ®Google Scholar
• Gimbel J, Linn R, Hale M, Nicholson B. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther 2005;12:311-19
   PubMedGoogle Scholar
• Galer BS, Gammaitoni AR, Oleka N, et al. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin 2004;20(Suppl 2):S5-12
   PubMed Web of Science ®Google Scholar
• Habib AS, Polascik TJ, Weizer AZ, et al. Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy. Anesth Analg 2009;108:1950-3
   PubMed Web of Science ®Google Scholar
• Cheville AL, Sloan JA, Northfelt DW, et al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phaseIII double-blind crossover study (N01CB). Support Care Cancer 2009;17:451-60
   PubMed Web of Science ®Google Scholar
• Jagetia GC, Rao SK, Baliga MS, et al. The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: a preliminary study. Phytother Res 2004;18:561-5
   PubMed Web of Science ®Google Scholar
• Hans G, Masquelier E, De Cock P. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Public Health 2007;7:170
   PubMed Web of Science ®Google Scholar
• Dajczman E, Gordon A, Kreisman H, et al. Long-term postthoracotomy pain. Chest 1991;99:270-4
   PubMed Web of Science ®Google Scholar
• Sihoe AD, Lee TW, Wan IY, et al. The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. Eur J Cardiothorac Surg 2006;29:795-9
   PubMed Web of Science ®Google Scholar
• Bartlett EE, Hutaserani Q. Lidocaine (xylocaine) for the relief of postoperative pain. J Am Med Womens Assoc 1962;17:809-15
   PubMedGoogle Scholar
• Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982;54:501-5
   PubMed Web of Science ®Google Scholar
• Cassuto J, Wallin G, Hogstrom S, et al. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 1985;64:971-4
   PubMed Web of Science ®Google Scholar
• Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000;87:7-17
   PubMed Web of Science ®Google Scholar
• Nagaro T, Shimizu C, Inoue H, et al. [The efficacy of intravenous lidocaine on various types of neuropathic pain]. Masui 1995;44:862-7
   PubMedGoogle Scholar
• Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991;45:145-8
   PubMed Web of Science ®Google Scholar
• Wilcke JR, Davis LE, Neff-Davis CA, et al. Pharmacokinetics of lidocaine and its active metabolites in dogs. J Vet Pharmacol Ther 1983;6:49-57
   PubMed Web of Science ®Google Scholar
• Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin J Pain 2000;16(2 Suppl):S80-5
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-40
   PubMed Web of Science ®Google Scholar
• Cuello AC, Polak JM, Pearse AG. SubstanceP: a naturally occurring transmitter in human spinal cord. Lancet 1976;2:1054-6
   PubMed Web of Science ®Google Scholar
• Oku R, Satoh M, Takagi H. Release of substanceP from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett 1987;74:315-19
   PubMed Web of Science ®Google Scholar
• Yaksh TL. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988;458:319-24
   PubMed Web of Science ®Google Scholar